How Permeation Enhancers Enable Oral Peptide Drugs: A Molecular View from SNAC and Semaglutide
For decades, oral delivery of peptide drugs has been one of the most persistent challenges in pharmaceutical science. Peptides are intrinsically ill-suited for oral administration: they are rapidly degraded by proteases and exhibit extremely low passive permeability across epithelial membranes. While injectable formulations have enabled the clinical success of many peptide therapeutics, oral delivery remains […]
LinkPeptide